ReP USP - Resultado da busca

Artigo de periodico
Vascular mechanisms involved in angiotensin II-induced venoconstriction in hypertensive rats (2011)
Loiola, Rodrigo Azevedo; Fernandes, Liliam; Eichler, Rosângela Aparecida; Passaglia, Rita de Cássia Aleixo Tostes; Fortes, Zuleica Bruno; Carvalho, Maria Helena Catelli de
Source: Peptides. Unidades: ICB, FMRP
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOIOLA, Rodrigo Azevedo et al. Vascular mechanisms involved in angiotensin II-induced venoconstriction in hypertensive rats. Peptides, v. 32, n. 10, p. 2116-2121, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.peptides.2011.09.011. Acesso em: 08 out. 2024.
APA
Loiola, R. A., Fernandes, L., Eichler, R. A., Passaglia, R. de C. A. T., Fortes, Z. B., & Carvalho, M. H. C. de. (2011). Vascular mechanisms involved in angiotensin II-induced venoconstriction in hypertensive rats. Peptides, 32( 10), 2116-2121. doi:10.1016/j.peptides.2011.09.011
NLM
Loiola RA, Fernandes L, Eichler RA, Passaglia R de CAT, Fortes ZB, Carvalho MHC de. Vascular mechanisms involved in angiotensin II-induced venoconstriction in hypertensive rats [Internet]. Peptides. 2011 ; 32( 10): 2116-2121.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/j.peptides.2011.09.011
Vancouver
Loiola RA, Fernandes L, Eichler RA, Passaglia R de CAT, Fortes ZB, Carvalho MHC de. Vascular mechanisms involved in angiotensin II-induced venoconstriction in hypertensive rats [Internet]. Peptides. 2011 ; 32( 10): 2116-2121.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/j.peptides.2011.09.011
Artigo de periodico
Enalapril treatment corrects the reduced response to bradykinin in diabetes increasing the B2 protein expression (2008)
Rastelli, Viviani Milan Ferreira; Oliveira, Maria Aparecida; Santos, Rosangela dos; Passaglia, Rita de Cássia Aleixo Tostes; Nigro, Dorothy; Carvalho, Maria Helena Catelli de; Fortes, Zuleica Bruno
Source: Peptides. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RASTELLI, Viviani Milan Ferreira et al. Enalapril treatment corrects the reduced response to bradykinin in diabetes increasing the B2 protein expression. Peptides, v. 29, n. 3, p. 404-411, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.peptides.2007.11.022. Acesso em: 08 out. 2024.
APA
Rastelli, V. M. F., Oliveira, M. A., Santos, R. dos, Passaglia, R. de C. A. T., Nigro, D., Carvalho, M. H. C. de, & Fortes, Z. B. (2008). Enalapril treatment corrects the reduced response to bradykinin in diabetes increasing the B2 protein expression. Peptides, 29( 3), 404-411. doi:10.1016/j.peptides.2007.11.022
NLM
Rastelli VMF, Oliveira MA, Santos R dos, Passaglia R de CAT, Nigro D, Carvalho MHC de, Fortes ZB. Enalapril treatment corrects the reduced response to bradykinin in diabetes increasing the B2 protein expression [Internet]. Peptides. 2008 ; 29( 3): 404-411.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/j.peptides.2007.11.022
Vancouver
Rastelli VMF, Oliveira MA, Santos R dos, Passaglia R de CAT, Nigro D, Carvalho MHC de, Fortes ZB. Enalapril treatment corrects the reduced response to bradykinin in diabetes increasing the B2 protein expression [Internet]. Peptides. 2008 ; 29( 3): 404-411.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/j.peptides.2007.11.022
Artigo de periodico
Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin (2007)
Rastelli, Viviani Milan Ferreira; Oliveira, Maria Aparecida; Santos, Rosangela dos; Passaglia, Rita de Cássia Aleixo Tostes; Nigro, Dorothy; Carvalho, Maria Helena Catelli de; Fortes, Zuleica Bruno
Source: Peptides. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RASTELLI, Viviani Milan Ferreira et al. Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin. Peptides, v. 28, n. 5, p. 1040-1049, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.peptides.2007.02.006. Acesso em: 08 out. 2024.
APA
Rastelli, V. M. F., Oliveira, M. A., Santos, R. dos, Passaglia, R. de C. A. T., Nigro, D., Carvalho, M. H. C. de, & Fortes, Z. B. (2007). Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin. Peptides, 28( 5), 1040-1049. doi:10.1016/j.peptides.2007.02.006
NLM
Rastelli VMF, Oliveira MA, Santos R dos, Passaglia R de CAT, Nigro D, Carvalho MHC de, Fortes ZB. Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin [Internet]. Peptides. 2007 ; 28( 5): 1040-1049.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/j.peptides.2007.02.006
Vancouver
Rastelli VMF, Oliveira MA, Santos R dos, Passaglia R de CAT, Nigro D, Carvalho MHC de, Fortes ZB. Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin [Internet]. Peptides. 2007 ; 28( 5): 1040-1049.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/j.peptides.2007.02.006
Artigo de periodico
Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide (2005)
Fernandes, Liliam; Loiola, Rodrigo Azevedo; Passaglia, Rita de Cássia Aleixo Tostes; Nigro, Dorothy; Fortes, Zuleica Bruno; Carvalho, Maria Helena Catelli de
Source: Peptides. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Liliam et al. Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide. Peptides, v. 26, p. 2458-2463, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.peptides.2005.05.025. Acesso em: 08 out. 2024.
APA
Fernandes, L., Loiola, R. A., Passaglia, R. de C. A. T., Nigro, D., Fortes, Z. B., & Carvalho, M. H. C. de. (2005). Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide. Peptides, 26, 2458-2463. doi:10.1016/j.peptides.2005.05.025
NLM
Fernandes L, Loiola RA, Passaglia R de CAT, Nigro D, Fortes ZB, Carvalho MHC de. Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide [Internet]. Peptides. 2005 ; 26 2458-2463.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/j.peptides.2005.05.025
Vancouver
Fernandes L, Loiola RA, Passaglia R de CAT, Nigro D, Fortes ZB, Carvalho MHC de. Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide [Internet]. Peptides. 2005 ; 26 2458-2463.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/j.peptides.2005.05.025
Artigo de periodico
Elevated glucose blocks angiotensin-(1-7) and bradykinin interaction: the role of cyclooxygenase products (2003)
Oliveira, M A.; Carvalho, Maria Helena Catelli; Nigro, Dorothy; Passaglia, Rita de Cassia Aleixo Tostes; Fortes, Zuleica Bruno
Source: Peptides. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, M A. et al. Elevated glucose blocks angiotensin-(1-7) and bradykinin interaction: the role of cyclooxygenase products. Peptides, v. 24, p. 449-454, 2003Tradução . . Disponível em: https://doi.org/10.1016/s0196-9781(03)00061-5. Acesso em: 08 out. 2024.
APA
Oliveira, M. A., Carvalho, M. H. C., Nigro, D., Passaglia, R. de C. A. T., & Fortes, Z. B. (2003). Elevated glucose blocks angiotensin-(1-7) and bradykinin interaction: the role of cyclooxygenase products. Peptides, 24, 449-454. doi:10.1016/s0196-9781(03)00061-5
NLM
Oliveira MA, Carvalho MHC, Nigro D, Passaglia R de CAT, Fortes ZB. Elevated glucose blocks angiotensin-(1-7) and bradykinin interaction: the role of cyclooxygenase products [Internet]. Peptides. 2003 ;24 449-454.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/s0196-9781(03)00061-5
Vancouver
Oliveira MA, Carvalho MHC, Nigro D, Passaglia R de CAT, Fortes ZB. Elevated glucose blocks angiotensin-(1-7) and bradykinin interaction: the role of cyclooxygenase products [Internet]. Peptides. 2003 ;24 449-454.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/s0196-9781(03)00061-5
Artigo de periodico
Angiotensin (1-7) and bradykinin interaction in diabetes mellitus in vivo study (2002)
Oliveira, M.; Carvalho, Maria Helena Catelli; Nigro, Dorothy; Passaglia, Rita de Cassia Aleixo Tostes ; Fortes, Zuleica Bruno
Source: Peptides. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, M. et al. Angiotensin (1-7) and bradykinin interaction in diabetes mellitus in vivo study. Peptides, v. 23, p. 1449-1455, 2002Tradução . . Disponível em: https://doi.org/10.1016/s0196-9781(02)00080-3. Acesso em: 08 out. 2024.
APA
Oliveira, M., Carvalho, M. H. C., Nigro, D., Passaglia, R. de C. A. T., & Fortes, Z. B. (2002). Angiotensin (1-7) and bradykinin interaction in diabetes mellitus in vivo study. Peptides, 23, 1449-1455. doi:10.1016/s0196-9781(02)00080-3
NLM
Oliveira M, Carvalho MHC, Nigro D, Passaglia R de CAT, Fortes ZB. Angiotensin (1-7) and bradykinin interaction in diabetes mellitus in vivo study [Internet]. Peptides. 2002 ; 23 1449-1455.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/s0196-9781(02)00080-3
Vancouver
Oliveira M, Carvalho MHC, Nigro D, Passaglia R de CAT, Fortes ZB. Angiotensin (1-7) and bradykinin interaction in diabetes mellitus in vivo study [Internet]. Peptides. 2002 ; 23 1449-1455.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/s0196-9781(02)00080-3

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Indexado em